CellFE

Applications. Elevate Gene Editing Performance Optimized Workflows for Complex Editing IPSC HSC T CELL Engineering Excellence in Every Cell with Ryva CellFE's gene

CellFE’s platform enables efficient multiplex CRISPR-Cas9 editing to engineer T cells. Managing toxicity and specificity of cell therapies relies on complex gene-editing mechanisms, requiring co-delivery of multiple gene-editing molecules.

How It Works. How it works A New Class of Cell Therapy Manufacturing The CellFE microfluidic gene editing technology maintains cell health, produces high yields, and

Products. products Dive into Limitless Innovation Speak to a Specialist Ryva System Ryva PUPs T-Rest Gentle and reliable The Ryva Advantage Gentle process

Application Note: Efficient Gene Editing of iPSCs. CellFE releases a cGMP-compatible workflow to support highly efficient gene editing of iPSCs via a non-viral approach for cell therapy manufacturing.

Resting T-Cell App Note Downloads.

CellFE Co-Founder Joins 10 Women-led Companies in Springboard Enterprise’s 2022 Innovation Bootcamp. Alla Zamarayeva, Co-Founder and CEO, has joined 10 women-led companies to participate in Springboard Enterprise’s 2022 Life Sciences Innovation Bootcamp.

CellFE co-founder Todd Sulchek, PhD presented at Cellicon Valley ‘21. Todd Sulchek, PhD, Co-founder of CellFE and Head of the Sulchek BioMEMS & Biomechanics Lab at Georgia Tech, will be participating as a speaker at

CellFE unveils research scale microfluidics-based cell engineering platform at BIO2022. The BIO International Convention (BIO) returns to in person meetings in San Diego, CA June 13-16 and CellFE will be there to present the research scale

CEO and Co-Founder Alla Zamarayeva presents in the Startup Showcase session at the ASGCT Annual. CEO and Co-Founder Alla Zamarayeva PhD presented recently at the Startup Showcase at the ASGCT 25th Annual Conference. The presentation covered how CellFE

The page describes the creativity, innovation, and determination behind the company's work.

The company aspires to create a future where all patients benefit from the curative potential of cell therapies.

The company offers products.

HSC App Note Request.

T-Cell App Note Request.

The company transforms how cell therapies are manufactured to enable affordable advanced treatments for all.

CellFE values the privacy of individuals who use its website and related services.

The page contains terms of use for CellFE, Inc. and its website at www.cellfebiotech.com.